CITADEL ADVISORS LLC

Holdings History for Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Symbol
ACRV on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned
1,721,867 shares
Security Ownership %
5.5%
Shares, Excluding Options vs Price
Value, Excluding Options

Kenneth Griffin ownership in Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV)

21 Nov 2025 - Kenneth Griffin has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,721,867 shares of Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV). This represents 5.5% ownership of the company. In their previous filing dated 14 Nov 2025, CITADEL ADVISORS LLC had reported owning 1,541,365 shares, indicating an increase of +12%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.